Processa Pharmaceuticals Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include Exelixis and Prolong Pharmaceuticals.
 Prolong Pharmaceuticals Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia. | |||
Founding Date | Founding Date 1990 | Founding Date 1994 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Alameda, US HQ | Locations South Plainfield, US HQ |
Employees | Employees 61821% increase | Employees 1,14712% decrease | Employees 225% increase |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 8.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($164.1m) (FY, 2025) | Net income $782.6m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 45m | Total funding raised N/A | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyProlong Pharmaceuticals
HQ
South Plainfield, US
Employees
22↑ 5% increase
Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia.
View company